Stockreport

Elevation Oncology downgraded as it halts lead asset on disappointing trials [Yahoo! Finance]

Piper Sandler Companies  (PIPR) 
Last piper sandler companies earnings: 5/1 08:04 am Check Earnings Report
PDF Analysts now see limited near-term catalysts, with Elevation pivoting to its HER3-targeted ADC, EO-1022, which is still in preclinical development. Piper Sandler down [Read more]